BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739 [PMID: 34754374 DOI: 10.4239/wjd.v12.i10.1731]
URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1731.htm
Number Citing Articles
1
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic, Milica M Borovcanin. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognitionWorld Journal of Psychiatry 2022; 12(9): 1183-1193 doi: 10.5498/wjp.v12.i9.1183
2
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic DysfunctionInternational Journal of Molecular Sciences 2022; 23(13): 7092 doi: 10.3390/ijms23137092
3
Nataša R. Mijailović, Katarina Vesic, Dragana Arsenijevic, Maja Milojević-Rakić, Milica M. Borovcanin. Galectin-3 Involvement in Cognitive Processes for New Therapeutic ConsiderationsFrontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.923811
4
Milica M Borovcanin, Katarina Vesic, Ivica Petrovic, Ivan P Jovanovic, Nataša R Mijailović. Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disordersWorld Journal of Diabetes 2023; 14(5): 481-493 doi: 10.4239/wjd.v14.i5.481